WHO ICTRP trial
Relative bioavailability of diclofenac potassium different formulations in…
CTRI/2012/11/003106 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2012/11/003106 |
|---|---|
| Public title | Relative bioavailability of diclofenac potassium different formulations in healthy subjects. |
| Scientific title | An open label, randomized, three period, six sequence, crossover study to determine the bioavailability of diclofenac potassium soft-gelatin capsule as compared to diclofenac potassium powder for oral solution and diclofenac potassium tablet in healthy subjects |
| Primary sponsor | Novartis Healthcare Private Limited |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | BA/BE |
| Phase | Phase 1/ Phase 2 |
| Countries | India |
| Interventions | Intervention1: Diclofenac potassium soft-gelatin (50mg) capsule: Single oral dose once daily for one day Control Intervention1: Diclofenac 50 mg tablet: Single oral dose once daily for one day Control Intervention2: Diclofenac 50 mg powder… |
| Registration date | Nov 14, 2012 |
| Target size | 78 |
| Secondary IDs | CCAT458M2101, Version No. v01 , dated 04-May-2012 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: